These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34656708)

  • 21. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis - case report and systematic review of dabigatran use.
    Di Pilla M; Barco S; Sacco C; Barosi G; Lodigiani C
    Vasa; 2021 Feb; 50(2):151-156. PubMed ID: 32597318
    [No Abstract]   [Full Text] [Related]  

  • 25. Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis.
    Giorgi-Pierfranceschi M; Mumoli N; Scarpioni R; Croci E; Dentali F
    J Am Geriatr Soc; 2016 Aug; 64(8):1748-50. PubMed ID: 27448437
    [No Abstract]   [Full Text] [Related]  

  • 26. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
    Bartholomew JR; Hursting MJ
    J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
    Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
    Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia.
    Singh N; Singh Lubana S; Tsai HM
    Am J Case Rep; 2020 May; 21():e922498. PubMed ID: 32469847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dabigatran as a Treatment Option for Heparin-Induced Thrombocytopenia.
    Nasiripour S; Saif M; Farasatinasab M; Emami S; Amouzegar A; Basi A; Mokhtari M
    J Clin Pharmacol; 2019 Jan; 59(1):107-111. PubMed ID: 30285276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban].
    Heil S
    Anaesthesist; 2009 Nov; 58(11):1119-22. PubMed ID: 19795099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytopenia following heparin flush.
    McNulty I; Katz E; Kim KY
    Prog Cardiovasc Nurs; 2005; 20(4):143-7. PubMed ID: 16276136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN; Rice L; Bartholomew JR; Whelton A
    Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban: for a few selected patients.
    Prescrire Int; 2013 Feb; 22(135):33-5. PubMed ID: 23444494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review.
    Dhakal P; Pathak R; Giri S; Murthy GS; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):87-91. PubMed ID: 26695419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.